Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...

In 1970, ischemic heart disease—mostly heart attacks—accounted for 91% of heart-related deaths. Today, that number has fallen ...

Heart attack survival odds have dramatically improved over the past 5 decades, but more people are dying from chronic cardiac ...

A new tool in understanding and improving nutrition for all now resides at the University of Alabama at Birmingham. The ...

Heart attacks are no longer the leading cause of heart disease-related death, but deaths from heart disease have still been ...

Investing in our troops’ health is not a soft strategy, it’s a hard imperative. Just as we fund advanced weapons, we must ...

What many don't realise is that chronic stress quietly chips away at heart health, increasing risks in ways that aren't immediately visible ...

Heart disease is the leading cause of death around the world. However, overall heart disease death rates over the past five ...

One of the main researchers, Professor Tore Bengtsson from Stockholm University, said this could be an exciting step forward.

The study, published in GeroScience, was led by researchers exploring ways to improve vascular health in older adults.

Scientists at The University of Texas at Arlington have identified a new enzyme that can be "turned off" to help the body ...